These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23867338)

  • 1. Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire.
    Kwakkenbos MJ; Bakker AQ; van Helden PM; Wagner K; Yasuda E; Spits H; Beaumont T
    Methods; 2014 Jan; 65(1):38-43. PubMed ID: 23867338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.
    Kwakkenbos MJ; Diehl SA; Yasuda E; Bakker AQ; van Geelen CM; Lukens MV; van Bleek GM; Widjojoatmodjo MN; Bogers WM; Mei H; Radbruch A; Scheeren FA; Spits H; Beaumont T
    Nat Med; 2010 Jan; 16(1):123-8. PubMed ID: 20023635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
    Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
    Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable long-term cultures of self-renewing B cells and their applications.
    Kwakkenbos MJ; van Helden PM; Beaumont T; Spits H
    Immunol Rev; 2016 Mar; 270(1):65-77. PubMed ID: 26864105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.
    Ishida T; Kobayashi N; Tojo T; Ishida S; Yamamoto T; Inoue J
    J Immunol; 1995 Dec; 155(12):5527-35. PubMed ID: 7499834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germinal Center B Cells Replace Their Antigen Receptors in Dark Zones and Fail Light Zone Entry when Immunoglobulin Gene Mutations are Damaging.
    Stewart I; Radtke D; Phillips B; McGowan SJ; Bannard O
    Immunity; 2018 Sep; 49(3):477-489.e7. PubMed ID: 30231983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
    Epeldegui M; Hung YP; McQuay A; Ambinder RF; Martínez-Maza O
    Mol Immunol; 2007 Feb; 44(5):934-42. PubMed ID: 16730063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian cell display for the discovery and optimization of antibody therapeutics.
    Bowers PM; Horlick RA; Kehry MR; Neben TY; Tomlinson GL; Altobell L; Zhang X; Macomber JL; Krapf IP; Wu BF; McConnell AD; Chau B; Berkebile AD; Hare E; Verdino P; King DJ
    Methods; 2014 Jan; 65(1):44-56. PubMed ID: 23792919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human monoclonal antibodies by the epstein-barr virus method.
    Steinitz M
    Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases.
    Willenbrock K; Bräuninger A; Hansmann ML
    Br J Haematol; 2007 Sep; 138(6):733-9. PubMed ID: 17672882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
    J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
    Takada E; Hata K; Mizuguchi J
    Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins.
    Pittner BT; Snow EC
    Cell Immunol; 1998 May; 186(1):55-62. PubMed ID: 9637765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
    Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
    Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
    Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
    Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
    Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.